🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the safety of each study vacc...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-02-19
Trial ID
NCT03384914
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Ireland Cancer Center
Start Date
2003-07
Trial ID
NCT00068614
Treatments Being Tested
RATIONALE: Vaccines made from the HER2/neu antigen may make the body build ...
Status
Completed
Location
University of Washington School of Medicine
Start Date
1996-04
Trial ID
NCT00003002
Treatments Being Tested
The purpose of this study is to determine whether ETBX-021 is safe and effe...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2017-03-04
Trial ID
NCT02751528
Treatments Being Tested
This phase I trial studies the side effects and best dose of vaccine therap...
Status
Recruiting
Location
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Start Date
2025-01-17
Trial ID
NCT06414733
Treatments Being Tested
This phase I trial studies the side effects and best dose of vaccine therap...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2011-06-21
Trial ID
NCT01376505
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT00017537
Treatments Being Tested
Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Status
Recruiting
Location
Biogenea Pharmaceuticals Ltd
Start Date
2025-07-01
Trial ID
NCT07077616
This is a prospective, open, single-center clinical study of the anti-HER2(...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-18
Trial ID
NCT06187506
Treatments Being Tested
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687